The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1049
March 26, 1999
View Complete Issue         Table of Contents 2019 
Modafinil for Narcolepsy
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Modafinil for Narcolepsy
March 26, 1999 (Issue: 1049)
Modafinil (Provigil), a benzhydryl sulfinylacetamide non-amphetamine stimulant that has been used in Europe since 1995, has now been approved by the FDA for treatment of excessive daytime sleepiness associated with narcolepsy.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Modafinil for Narcolepsy
Article code: 1049b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.